Milestone Pharmaceuticals Inc. (MIST): Price and Financial Metrics
MIST Price/Volume Stats
| Current price | $2.14 | 52-week high | $2.75 |
| Prev. close | $1.98 | 52-week low | $1.12 |
| Day low | $2.00 | Volume | 701,290 |
| Day high | $2.23 | Avg. volume | 624,683 |
| 50-day MA | $1.93 | Dividend yield | N/A |
| 200-day MA | $1.62 | Market Cap | 114.12M |
MIST Stock Price Chart Interactive Chart >
Milestone Pharmaceuticals Inc. (MIST) Company Bio
Milestone Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. It designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.
MIST Price Returns
| 1-mo | 18.89% |
| 3-mo | 45.58% |
| 6-mo | 43.62% |
| 1-year | 39.87% |
| 3-year | -68.94% |
| 5-year | -90.04% |
| YTD | -9.32% |
| 2024 | 41.32% |
| 2023 | -57.83% |
| 2022 | -39.54% |
| 2021 | -2.24% |
| 2020 | -58.15% |
Loading social stream, please wait...